Type 1 Diabetes Clinical Trial Patient Recruitment

Type 1 diabetes patient recruitment for insulin therapy, islet cell, and disease-modifying clinical trials.

Who qualifies: Adults and adolescents with T1DM (C-peptide <0.2 nmol/L) with HbA1c 7.0–10.0%.

Recruitment challenges: C-peptide and autoantibody confirmation requirements.

Our approach: Endocrinology and diabetes center referral networks with C-peptide pre-screening.